Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity

Masato Asanuma, Ikuko Miyazaki, Yuri Kikkawa, Naotaka Kimoto, Mika Takeshima, Shinki Murakami, Ko Miyoshi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Prostaglandin H synthase exerts not only cyclooxygenase activity but also peroxidase activity. The latter activity of the enzyme is thought to couple with oxidation of dopamine to dopamine quinone. Therefore, it has been proposed that cyclooxygenase inhibitors could suppress dopamine quinone formation. In the present study, we examined effects of various cyclooxygenase inhibitors against excess methyl L-3,4-dihydroxyphenylalanine (L-DOPA)-induced quinoprotein (protein-bound quinone) formation and neurotoxicity using dopaminergic CATH.a cells. The treatment with aspirin inhibited excess methyl L-DOPA-induced quinoprotein formation and cell death. However, acetaminophen did not show protective effects, and indomethacin and meloxicam rather aggravated these methyl L-DOPA-induced changes. Aspirin and indomethacin did not affect the level of glutathione that exerts quenching dopamine quinone in dopaminergic cells. In contrast with inhibiting effects of higher dose in the previous reports, relatively lower dose of aspirin that affected methyl L-DOPA-induced quinoprotein formation and cell death failed to prevent cyclooxygenase-induced dopamine chrome generation in cell-free system. Furthermore, aspirin but not acetaminophen or meloxicam showed direct dopamine quinone-scavenging effects in dopamine-semiquinone generating systems. The present results suggest that cyclooxygenase shows little contribution to dopamine oxidation in dopaminergic cells and that protective effects of aspirin against methyl L-DOPA-induced dopamine quinone neurotoxicity are based on its cyclooxygenaseindependent property.

Original languageEnglish
Pages (from-to)1944-1951
Number of pages8
JournalNeurochemical Research
Volume37
Issue number9
DOIs
Publication statusPublished - Sep 2012

Fingerprint

Levodopa
Neuroprotective Agents
Prostaglandin-Endoperoxide Synthases
Aspirin
meloxicam
Dopamine
Cyclooxygenase Inhibitors
Cell death
Acetaminophen
Indomethacin
Cell Death
Oxidation
Cell-Free System
Scavenging
Peroxidase
Glutathione
Quenching
dopamine quinone
Enzymes
Proteins

Keywords

  • Aspirin
  • Cyclooxygenase
  • Dopamine quinone
  • Oxidation
  • Parkinson's disease

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Biochemistry

Cite this

Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity. / Asanuma, Masato; Miyazaki, Ikuko; Kikkawa, Yuri; Kimoto, Naotaka; Takeshima, Mika; Murakami, Shinki; Miyoshi, Ko.

In: Neurochemical Research, Vol. 37, No. 9, 09.2012, p. 1944-1951.

Research output: Contribution to journalArticle

Asanuma, Masato ; Miyazaki, Ikuko ; Kikkawa, Yuri ; Kimoto, Naotaka ; Takeshima, Mika ; Murakami, Shinki ; Miyoshi, Ko. / Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity. In: Neurochemical Research. 2012 ; Vol. 37, No. 9. pp. 1944-1951.
@article{ef21cb825cd24dfd93476e962d2bb7fe,
title = "Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity",
abstract = "Prostaglandin H synthase exerts not only cyclooxygenase activity but also peroxidase activity. The latter activity of the enzyme is thought to couple with oxidation of dopamine to dopamine quinone. Therefore, it has been proposed that cyclooxygenase inhibitors could suppress dopamine quinone formation. In the present study, we examined effects of various cyclooxygenase inhibitors against excess methyl L-3,4-dihydroxyphenylalanine (L-DOPA)-induced quinoprotein (protein-bound quinone) formation and neurotoxicity using dopaminergic CATH.a cells. The treatment with aspirin inhibited excess methyl L-DOPA-induced quinoprotein formation and cell death. However, acetaminophen did not show protective effects, and indomethacin and meloxicam rather aggravated these methyl L-DOPA-induced changes. Aspirin and indomethacin did not affect the level of glutathione that exerts quenching dopamine quinone in dopaminergic cells. In contrast with inhibiting effects of higher dose in the previous reports, relatively lower dose of aspirin that affected methyl L-DOPA-induced quinoprotein formation and cell death failed to prevent cyclooxygenase-induced dopamine chrome generation in cell-free system. Furthermore, aspirin but not acetaminophen or meloxicam showed direct dopamine quinone-scavenging effects in dopamine-semiquinone generating systems. The present results suggest that cyclooxygenase shows little contribution to dopamine oxidation in dopaminergic cells and that protective effects of aspirin against methyl L-DOPA-induced dopamine quinone neurotoxicity are based on its cyclooxygenaseindependent property.",
keywords = "Aspirin, Cyclooxygenase, Dopamine quinone, Oxidation, Parkinson's disease",
author = "Masato Asanuma and Ikuko Miyazaki and Yuri Kikkawa and Naotaka Kimoto and Mika Takeshima and Shinki Murakami and Ko Miyoshi",
year = "2012",
month = "9",
doi = "10.1007/s11064-012-0813-2",
language = "English",
volume = "37",
pages = "1944--1951",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity

AU - Asanuma, Masato

AU - Miyazaki, Ikuko

AU - Kikkawa, Yuri

AU - Kimoto, Naotaka

AU - Takeshima, Mika

AU - Murakami, Shinki

AU - Miyoshi, Ko

PY - 2012/9

Y1 - 2012/9

N2 - Prostaglandin H synthase exerts not only cyclooxygenase activity but also peroxidase activity. The latter activity of the enzyme is thought to couple with oxidation of dopamine to dopamine quinone. Therefore, it has been proposed that cyclooxygenase inhibitors could suppress dopamine quinone formation. In the present study, we examined effects of various cyclooxygenase inhibitors against excess methyl L-3,4-dihydroxyphenylalanine (L-DOPA)-induced quinoprotein (protein-bound quinone) formation and neurotoxicity using dopaminergic CATH.a cells. The treatment with aspirin inhibited excess methyl L-DOPA-induced quinoprotein formation and cell death. However, acetaminophen did not show protective effects, and indomethacin and meloxicam rather aggravated these methyl L-DOPA-induced changes. Aspirin and indomethacin did not affect the level of glutathione that exerts quenching dopamine quinone in dopaminergic cells. In contrast with inhibiting effects of higher dose in the previous reports, relatively lower dose of aspirin that affected methyl L-DOPA-induced quinoprotein formation and cell death failed to prevent cyclooxygenase-induced dopamine chrome generation in cell-free system. Furthermore, aspirin but not acetaminophen or meloxicam showed direct dopamine quinone-scavenging effects in dopamine-semiquinone generating systems. The present results suggest that cyclooxygenase shows little contribution to dopamine oxidation in dopaminergic cells and that protective effects of aspirin against methyl L-DOPA-induced dopamine quinone neurotoxicity are based on its cyclooxygenaseindependent property.

AB - Prostaglandin H synthase exerts not only cyclooxygenase activity but also peroxidase activity. The latter activity of the enzyme is thought to couple with oxidation of dopamine to dopamine quinone. Therefore, it has been proposed that cyclooxygenase inhibitors could suppress dopamine quinone formation. In the present study, we examined effects of various cyclooxygenase inhibitors against excess methyl L-3,4-dihydroxyphenylalanine (L-DOPA)-induced quinoprotein (protein-bound quinone) formation and neurotoxicity using dopaminergic CATH.a cells. The treatment with aspirin inhibited excess methyl L-DOPA-induced quinoprotein formation and cell death. However, acetaminophen did not show protective effects, and indomethacin and meloxicam rather aggravated these methyl L-DOPA-induced changes. Aspirin and indomethacin did not affect the level of glutathione that exerts quenching dopamine quinone in dopaminergic cells. In contrast with inhibiting effects of higher dose in the previous reports, relatively lower dose of aspirin that affected methyl L-DOPA-induced quinoprotein formation and cell death failed to prevent cyclooxygenase-induced dopamine chrome generation in cell-free system. Furthermore, aspirin but not acetaminophen or meloxicam showed direct dopamine quinone-scavenging effects in dopamine-semiquinone generating systems. The present results suggest that cyclooxygenase shows little contribution to dopamine oxidation in dopaminergic cells and that protective effects of aspirin against methyl L-DOPA-induced dopamine quinone neurotoxicity are based on its cyclooxygenaseindependent property.

KW - Aspirin

KW - Cyclooxygenase

KW - Dopamine quinone

KW - Oxidation

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84866740549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866740549&partnerID=8YFLogxK

U2 - 10.1007/s11064-012-0813-2

DO - 10.1007/s11064-012-0813-2

M3 - Article

C2 - 22674083

AN - SCOPUS:84866740549

VL - 37

SP - 1944

EP - 1951

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 9

ER -